US SB2260 | 2017-2018 | 115th Congress
Status
Spectrum: Moderate Partisan Bill (Democrat 6-1)
Status: Introduced on December 21 2017 - 25% progression, died in committee
Action: 2017-12-21 - Read twice and referred to the Committee on Finance.
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on December 21 2017 - 25% progression, died in committee
Action: 2017-12-21 - Read twice and referred to the Committee on Finance.
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Opioids and STOP Pain Initiative Act This bill establishes and provides funds for the Opioids and STOP Pain Initiative at the National Institutes of Health (NIH) to support pain-related research, including: understanding pain, therapies for chronic pain, and alternatives to opioids for pain treatment as directed in the Comprehensive Addiction and Recovery Act of 2016; improving options and evidence for medication-assisted treatment and opioid overdose reversal treatments; and supporting the Federal Pain Research Strategy. NIH must establish the Pain Therapy Screening Program to award grants to support the development of new pre-clinical models for pain disorders, and the application of these models in drug, device, or other therapy screening.
Title
Opioids and STOP Pain Initiative Act
Sponsors
Sen. Brian Schatz [D-HI] | Sen. Christopher Coons [D-DE] | Sen. Bill Nelson [D-FL] | Sen. Jon Tester [D-MT] |
Sen. Angus King [I-ME] | Sen. Sheldon Whitehouse [D-RI] | Sen. Robert Casey [D-PA] |
History
Date | Chamber | Action |
---|---|---|
2017-12-21 | Senate | Read twice and referred to the Committee on Finance. |
Same As/Similar To
HB4733 (Related) 2018-01-03 - Referred to the Subcommittee on Health.
HB5531 (Related) 2018-05-22 - Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
HB5531 (Related) 2018-05-22 - Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Subjects
Charitable contributions
Congressional oversight
Department of Health and Human Services
Drug therapy
Drug trafficking and controlled substances
Health
Health information and medical records
Health programs administration and funding
Health promotion and preventive care
Health technology, devices, supplies
Income tax credits
Medical research
National Institutes of Health (NIH)
Prescription drugs
Research administration and funding
Research and development
Social work, volunteer service, charitable organizations
User charges and fees
Congressional oversight
Department of Health and Human Services
Drug therapy
Drug trafficking and controlled substances
Health
Health information and medical records
Health programs administration and funding
Health promotion and preventive care
Health technology, devices, supplies
Income tax credits
Medical research
National Institutes of Health (NIH)
Prescription drugs
Research administration and funding
Research and development
Social work, volunteer service, charitable organizations
User charges and fees
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/115th-congress/senate-bill/2260/all-info |
Text | https://www.congress.gov/115/bills/s2260/BILLS-115s2260is.pdf |